Thurs. Apr 8, 2021 07:00 PM - Dr. Michele Dagostine and Adamas Pharmaceuticals present about Gocovri
Dr. Michele Dagostine, of the Hartford HealthCare Medical Group, Chase Family Movement Disorders Center, along with Adamas Pharmaceuticals Inc., maker of Gocovri (amantadine extended release capsules). On Feb. 1 the FDA approved Gocovri to also treat “off” episodes in patients taking Levodopa.
Dr. Michele Dagostine, of the Hartford HealthCare Medical Group, Chase Family Movement Disorders Center, along with Adamas Pharmaceuticals Inc., maker of Gocovri (amantadine extended release capsules). On Feb. 1 the FDA approved Gocovri to also treat “off” episodes in patients taking Levodopa.